Cost Analysis and Rationale for Universal Pharmacare in Canada

The Liberal-NDP supply-and-confidence deal has passed another test. The two parties managed to table a pharmacare bill before the March 1 deadline. But the compromise legislation is a limited program, supplying universal, single-payer coverage to only two classes of drugs.

Marieke Walsh, the Globe’s Senior Political Reporter, explains how the program will work and how much it will cost.

Questions? Comments? Ideas? Email us at thedecibel@globeandmail.com